Henry Ford Cancer Institute — Detroit, Michigan

Henry Ford Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Institute has participated in 29 clinical trials with 19 currently active.

Therapeutic areas: Leukemia, Myeloid, Acute, Solid Tumor, Adult, Metastatic Solid Tumor.

Sponsors: Delta-Fly Pharma, Inc., Sairopa B.V., Scholar Rock, Inc..

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Institute?

Henry Ford Cancer Institute has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Institute conducted?

Henry Ford Cancer Institute has 29 clinical trials on record, with 19 currently active. Their work covers Leukemia, Myeloid, Acute, Solid Tumor, Adult, Metastatic Solid Tumor.

Is Henry Ford Cancer Institute accredited by Crixeo Health?

Yes — Henry Ford Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Henry Ford Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.